Exclusivity Information
Prascend holds 1 exclusivity out of which 1 has expired. Details of Prascend's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Sep 07, 2016 |
Prascend Petitions
Details of Prascend's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Kindred Biosciences | Approved | 29 Sep, 2017 | The proposed change is in dosage form. The RLNAD is approved as a compressed tablet. The proposed change is for an extruded pellet to be used as a top-dress on the horse's daily ration. |
About Prascend
Prascend is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Prascend uses
Pergolide Mesylate as the active
ingredient.
Active Ingredient:
Prascend uses
Pergolide Mesylate as the active ingredient.
Check out other Drugs and Companies using
Pergolide Mesylate ingredient.